vs
百胜餐饮集团（LCUT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
百胜餐饮集团的季度营收约是再鼎医药的1.6倍（$204.1M vs $127.1M），再鼎医药同比增速更快（17.1% vs -5.2%），百胜餐饮集团自由现金流更多（$2.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 19.8%）
百胜餐饮集团是美国跨国快餐企业，1977年百事可乐收购肯德基、必胜客、塔可Bell后将其整合为旗下子公司，1997年百事剥离该业务板块后正式独立为百胜集团。集团目前运营肯德基、必胜客、塔可Bell、哈比特汉堡等多个餐饮品牌，同时布局相关餐饮科技业务，门店网络遍布全球多个国家和地区。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
LCUT vs ZLAB — 直观对比
营收规模更大
LCUT
是对方的1.6倍
$127.1M
营收增速更快
ZLAB
高出22.3%
-5.2%
自由现金流更多
LCUT
多$29.3M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
19.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $204.1M | $127.1M |
| 净利润 | $18.2M | — |
| 毛利率 | 38.6% | 51.0% |
| 营业利润率 | 9.8% | -54.6% |
| 净利率 | 8.9% | — |
| 营收同比 | -5.2% | 17.1% |
| 净利润同比 | 103.5% | — |
| 每股收益（稀释后） | $0.83 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCUTZLAB
| Q4 25 | $204.1M | $127.1M | ||
| Q3 25 | $171.9M | $115.4M | ||
| Q2 25 | $131.9M | $109.1M | ||
| Q1 25 | $140.1M | $105.7M | ||
| Q4 24 | $215.2M | $108.5M | ||
| Q3 24 | $183.8M | $101.8M | ||
| Q2 24 | $141.7M | $100.1M | ||
| Q1 24 | $142.2M | $87.1M |
净利润LCUTZLAB
| Q4 25 | $18.2M | — | ||
| Q3 25 | $-1.2M | $-36.0M | ||
| Q2 25 | $-39.7M | $-40.7M | ||
| Q1 25 | $-4.2M | $-48.4M | ||
| Q4 24 | $8.9M | — | ||
| Q3 24 | $344.0K | $-41.7M | ||
| Q2 24 | $-18.2M | $-80.3M | ||
| Q1 24 | $-6.3M | $-53.5M |
毛利率LCUTZLAB
| Q4 25 | 38.6% | 51.0% | ||
| Q3 25 | 35.1% | 59.5% | ||
| Q2 25 | 38.6% | 60.6% | ||
| Q1 25 | 36.1% | 63.6% | ||
| Q4 24 | 37.7% | 61.5% | ||
| Q3 24 | 36.7% | 64.1% | ||
| Q2 24 | 38.5% | 64.9% | ||
| Q1 24 | 40.5% | 61.4% |
营业利润率LCUTZLAB
| Q4 25 | 9.8% | -54.6% | ||
| Q3 25 | 3.9% | -42.3% | ||
| Q2 25 | -28.2% | -50.3% | ||
| Q1 25 | 0.8% | -53.3% | ||
| Q4 24 | 7.2% | -62.6% | ||
| Q3 24 | 4.7% | -66.6% | ||
| Q2 24 | 0.8% | -76.0% | ||
| Q1 24 | 1.3% | -80.7% |
净利率LCUTZLAB
| Q4 25 | 8.9% | — | ||
| Q3 25 | -0.7% | -31.2% | ||
| Q2 25 | -30.1% | -37.3% | ||
| Q1 25 | -3.0% | -45.8% | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 0.2% | -40.9% | ||
| Q2 24 | -12.8% | -80.2% | ||
| Q1 24 | -4.4% | -61.4% |
每股收益（稀释后）LCUTZLAB
| Q4 25 | $0.83 | $-0.05 | ||
| Q3 25 | $-0.05 | $-0.03 | ||
| Q2 25 | $-1.83 | $-0.04 | ||
| Q1 25 | $-0.19 | $-0.04 | ||
| Q4 24 | $0.41 | $-0.09 | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $-0.85 | $-0.08 | ||
| Q1 24 | $-0.29 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $689.6M |
| 总债务越低越好 | $135.0M | — |
| 股东权益账面价值 | $202.3M | $715.5M |
| 总资产 | $572.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.67× | — |
8季度趋势，按日历期对齐
现金及短期投资LCUTZLAB
| Q4 25 | $4.3M | $689.6M | ||
| Q3 25 | $12.1M | $717.2M | ||
| Q2 25 | $12.0M | $732.2M | ||
| Q1 25 | $10.4M | $757.3M | ||
| Q4 24 | $2.9M | $779.7M | ||
| Q3 24 | $6.0M | $616.1M | ||
| Q2 24 | $3.4M | $630.0M | ||
| Q1 24 | $4.6M | $650.8M |
总债务LCUTZLAB
| Q4 25 | $135.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $142.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LCUTZLAB
| Q4 25 | $202.3M | $715.5M | ||
| Q3 25 | $184.6M | $759.9M | ||
| Q2 25 | $185.8M | $791.7M | ||
| Q1 25 | $225.7M | $810.8M | ||
| Q4 24 | $229.9M | $840.9M | ||
| Q3 24 | $220.9M | $667.7M | ||
| Q2 24 | $219.8M | $704.2M | ||
| Q1 24 | $223.7M | $762.2M |
总资产LCUTZLAB
| Q4 25 | $572.6M | $1.2B | ||
| Q3 25 | $581.1M | $1.2B | ||
| Q2 25 | $551.9M | $1.2B | ||
| Q1 25 | $594.6M | $1.2B | ||
| Q4 24 | $634.3M | $1.2B | ||
| Q3 24 | $668.7M | $985.3M | ||
| Q2 24 | $617.0M | $987.4M | ||
| Q1 24 | $602.7M | $988.4M |
负债/权益比LCUTZLAB
| Q4 25 | 0.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $2.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | 1.3% | -21.0% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.21× | — |
| 过去12个月自由现金流最近4个季度 | $3.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流LCUTZLAB
| Q4 25 | $3.7M | $-26.0M | ||
| Q3 25 | $-22.2M | $-32.0M | ||
| Q2 25 | $9.3M | $-31.0M | ||
| Q1 25 | $16.7M | $-61.7M | ||
| Q4 24 | $20.3M | $-55.8M | ||
| Q3 24 | $-22.7M | $-26.8M | ||
| Q2 24 | $10.4M | $-42.2M | ||
| Q1 24 | $10.5M | $-90.1M |
自由现金流LCUTZLAB
| Q4 25 | $2.6M | $-26.7M | ||
| Q3 25 | $-22.7M | $-35.0M | ||
| Q2 25 | $8.2M | $-33.9M | ||
| Q1 25 | $15.1M | $-63.2M | ||
| Q4 24 | $19.7M | $-58.4M | ||
| Q3 24 | $-23.2M | $-28.2M | ||
| Q2 24 | $9.9M | $-42.9M | ||
| Q1 24 | $9.9M | $-91.1M |
自由现金流率LCUTZLAB
| Q4 25 | 1.3% | -21.0% | ||
| Q3 25 | -13.2% | -30.4% | ||
| Q2 25 | 6.2% | -31.1% | ||
| Q1 25 | 10.8% | -59.9% | ||
| Q4 24 | 9.1% | -53.8% | ||
| Q3 24 | -12.6% | -27.7% | ||
| Q2 24 | 7.0% | -42.9% | ||
| Q1 24 | 7.0% | -104.5% |
资本支出强度LCUTZLAB
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.9% | 2.6% | ||
| Q1 25 | 1.1% | 1.5% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | 0.3% | 1.3% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 0.4% | 1.1% |
现金转化率LCUTZLAB
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | -65.89× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCUT
| Kitchenware | $114.3M | 56% |
| Tableware | $41.7M | 20% |
| Home Solutions | $29.4M | 14% |
| Other | $18.8M | 9% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
